insulin glargine-yfgn
now available
Affordable, long-acting insulin glargine-yfgn in prefilled pens.
Available at the lowest list price in this market. How to order >
Not intended to represent an actual product
Get additional information
Consumer Fact Sheet >
Pharmacy Fact Sheet >
Civica insulin glargine-yfgn is now available in the United States. In California, the product carries the CalRx® brand.
Civica insulin glargine-yfgn is available to pharmacies across the United States for $45 for a box of five prefilled pens, a significant discount in many cases to current prices.
Civica recommends that pharmacies set a maximum price for consumers — per our MaxRP® policy — of no more than $55 per box, and that health plans set a consumer out-of-pocket price of zero dollars.
This pricing remains stable and transparent, unlike other manufacturers’ copay assistance programs that require registration and can change anytime.
Civica’s affordable insulin initiative
In 2022, Civica announced plans to manufacture and distribute insulins that, once approved, would be available to people with diabetes at significantly lower prices than insulins currently on the market.
The availability of affordable insulins benefits people with diabetes who have been forced to choose between life-sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out-of-pocket for their medications.
Civica, along with CivicaScript and the Civica Foundation, is collaborating on this effort with partners that represent nearly every corner of the diabetes ecosystem to advance this initiative.
Collaborations enable affordable insulin
The multi-year agreement between Civica and Biocon Biologics creates an arrangement where Biocon Biologics manufactures and supplies insulin glargine-yfgn to Civica, and Civica commercializes under Biocon Biologics’ existing marketing approval (a private label agreement).
Civica distributes, promotes and sells the medicine in the United States under a separate Civica label and packaging, and in California, the product carries the CalRx® brand.
IMPORTANT SAFETY INFORMATION
Do not share your pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not use Insulin Glargine-yfgn if you are having an episode of low blood sugar or if you are allergic to insulin glargine products or any of the ingredients in Insulin Glargine-yfgn.
Do NOT reuse needles.
Before using Insulin Glargine-yfgn, tell your healthcare provider about all your medical conditions including if you:
• have liver or kidney problems.
• take other medicines, especially ones called TZDs (thiazolidinediones).
• have heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Insulin Glargine-yfgn.
• are pregnant, planning to become pregnant, or are breastfeeding. It is not known if Insulin Glargine-yfgn may harm your unborn baby or breastfeeding baby.
Tell your healthcare provider about all the medicines you take including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Before you start using Insulin Glargine-yfgn, talk to your healthcare provider about low blood sugar and how to manage it.
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged. While injecting Insulin Glargine-yfgn, do not press hard, slowly push the injection button to inject the dose. Tell your doctor if you have any new or worsening symptoms of heart failure, including shortness of breath, swelling of your ankles or feet, sudden weight gain.
Insulin Glargine-yfgn should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Insulin Glargine-yfgn. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.
Do NOT dilute or mix Insulin Glargine-yfgn with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Insulin Glargine-yfgn must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.
While using Insulin Glargine-yfgn, do not drive or operate heavy machinery until you know how Insulin Glargine-yfgn affects you. You should not drink alcohol or use other medicines that contain alcohol.
The most common side effect of insulin, including Insulin Glargine-yfgn, is low blood sugar (hypoglycemia), which may be serious and life threatening.
Signs and symptoms that may indicate low blood sugar include dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood change, hunger.
Insulin Glargine-yfgn may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have: a rash over your whole body, trouble breathing, shortness of breath, a fast heartbeat, sweating, swelling of your face, tongue, or throat, extreme drowsiness, dizziness, or confusion.
Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, allergic reactions and skin thickening or pits at the injection site.
Important Safety Information for Insulin Glargine-yfgn injection pen
Insulin Glargine-yfgn pen is a disposable single-patient-use prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.
These are not all the possible side effects of Insulin Glargine-yfgn. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
This summary does not include all the information about Insulin Glargine-yfgn and is not meant to take the place of a discussion with your healthcare provider about your treatment.
What is Insulin Glargine-yfgn injection 100 Units/mL?
Insulin Glargine-yfgn is a prescription long-acting man-made insulin used to control high blood sugar in adults and children with diabetes.
• Insulin Glargine-yfgn is not for use to treat diabetic ketoacidosis.